Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-65.75%Free Cash Flow Yield
VS
Market
Sector
Industry
History
$ 10.09Close
$ 2.51 - $ 10.09 52-Week Range
Ticker Information
Ticker
FDMTCompany Name
4D MOLECULAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ4D MOLECULAR THERAPEUTICS INC - Free Cash Flow Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FDMT - FCF Yield Historical data
| Date | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
|---|---|---|---|
| 6/30/2025 | $ -169.81M | -65.75% | $ 258.26M |
| 3/31/2025 | $ -156.96M | -104.58% | $ 150.09M |
| 12/31/2024 | $ -138.37M | -65.97% | $ 209.75M |
| 9/30/2024 | $ -116.76M | -32.76% | $ 356.42M |
| 6/30/2024 | $ -87.17M | -11.39% | $ 765.51M |
| 3/31/2024 | $ -79.44M | -5.99% | $ 1.33B |
| 12/31/2023 | $ -78.56M | -5.63% | $ 1.39B |
| 9/30/2023 | $ -76.67M | -17.08% | $ 448.91M |
| 6/30/2023 | $ -98.08M | -13.69% | $ 716.58M |
| 3/31/2023 | $ -97.18M | -17.29% | $ 562.1M |
Key Performance Insights, Last 5 Years
- 4D MOLECULAR THERAPEUTICS INC's latest trailing twelve months (TTM) FCF Yield stands at -4.92%.
- Over the past 5 years, 4D MOLECULAR THERAPEUTICS INC's average FCF Yield has been -28.5%.
- The median FCF Yield for 4D MOLECULAR THERAPEUTICS INC during this period was -17.08%
- 4D MOLECULAR THERAPEUTICS INC reached its highest FCF Yield over the past 5 years at -4.92%.
- The lowest FCF Yield recorded by 4D MOLECULAR THERAPEUTICS INC in the same timeframe -104.58%
4D MOLECULAR THERAPEUTICS INC's FCF Yield vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF Yield Benchmarks
Similar metrics to Market Cap:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
Definition of Free Cash Flow Yield
[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.FCF / Market Cap
(=) FCF Yield FCF Yield for 4D MOLECULAR THERAPEUTICS INC is calculated as follows: FCF [ $ -51.91M ] / Market Cap [ $ 1.06B ]
(=) FCF Yield [ -4.92% ] FDMT - Free Cash Flow Yield, Last 5 years
-104.58%
Minimum
Mar 31, 2025
-4.92%
Maximum
Dec 31, 2020
-28.5%
Average
-17.08%
Median
FCF Yield Benchmark AnalysisMarket
The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.59% with a standard deviation of 11.38%.
The following table provides additional summary stats:
FCF Yield in the Market:
| filtered constituents | 3.58K |
|---|---|
| min | -33.87% |
| max | 37.55% |
| average | 1.59% |
| median | 3.22% |
| std | 11.38% |